Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Cathepsin K inhibitors identified at Amura for treating bone disorders

Aug. 20, 2009

Lilly reports results from phase III GJAD GENERATIONS trial of arzoxifene

Aug. 19, 2009

GSK works toward oral calcium-sensing receptor antagonists for osteoporosis

Aug. 19, 2009

GlycoMimetics receives grant to study E-selectin small molecule antagonists

Aug. 19, 2009

BioSante reports LibiGel safety data from phase III program

Aug. 19, 2009

Lilly submits NDA in Japan for GLP-1 receptor agonist exenatide for diabetes

Aug. 18, 2009

Oxygen to commence phase II Oxycyte trial in traumatic brain injury

Aug. 18, 2009

First launch for Onglyza in U.S.

Aug. 17, 2009

FDA approves Pharming's IND for Prodarsan in Cockayne syndrome

Aug. 17, 2009

CB1R antagonist AM-6545 improves plasma lipid profile and glucose tolerance in obese mice

Aug. 17, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...